首页> 外文期刊>Annals of Thoracic Medicine >Differences in care between general medicine and respiratory specialists in the management of patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease
【24h】

Differences in care between general medicine and respiratory specialists in the management of patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease

机译:住院治疗慢性阻塞性肺疾病急性加重的普通药物和呼吸系统专家之间的护理差异

获取原文
获取外文期刊封面目录资料

摘要

Context: Hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) may be managed by either respiratory specialists (RS) or general medicine physicians (GMP). While previous studies have audited the hospital AECOPD management of RS, only a small number of studies have evaluated the management of GMP. Aims: The aims of this study were to firstly examine the differences in AECOPD management of GMP and RS and secondly compare their care to national COPD guidelines. Methods: A retrospective review was undertaken of consecutive AECOPD patients admitted to two hospitals (one hospital where all AECOPD patients were managed by RS and another where all AECOPD patients were managed by GMP) over a 3-month period. Electronic medical records, medical case notes, pathology and radiology data for the admission were reviewed. Results: There were 201 COPD exacerbations in 169 patients (49.7% male, mean age 72.3). GMP managed 84 (41.7%) exacerbations. In comparison to RS, GMP performed fewer spirometry tests, blood gas analysis and less frequently treated patients with guideline-recommended medications. Referral to pulmonary rehabilitation was poor for both groups of clinicians. Median length of stay was shorter in GMP patients versus RS patients (3 days vs. 5 days, P = 0.001). There were no differences in the 12-month re-admission (41.7% vs. 38.5%, P = 0.664) and mortality rates (10.7% vs. 6%, P = 0.292) between both groups of patients. Conclusion: Our study found differences in the hospital AECOPD management of GMP and RS, but these did not translate into different clinical outcomes between their patients. We also found suboptimal adherence to national COPD guidelines, suggesting that there is scope for improvement in the AECOPD management of both groups of clinicians.
机译:背景:患有慢性阻塞性肺疾病(AECOPD)急性加重的住院患者可以由呼吸专科医师(RS)或普通内科医师(GMP)治疗。尽管先前的研究对RS的医院AECOPD管理进行了审计,但只有少数研究对GMP的管理进行了评估。目的:本研究的目的是首先检查GMP和RS的AECOPD管理的差异,其次将它们的护理与国家COPD指南进行比较。方法:回顾性回顾了三个月期间入院的两家医院的连续AECOPD患者(一所医院所有AECOPD患者均由RS治疗,另一所医院所有AECOPD患者均由GMP治疗)。审查了入院的电子病历,病历记录,病理学和放射学数据。结果:169例患者出现201例COPD病情加重(男性49.7%,平均年龄72.3)。 GMP处理了84次(41.7%)的急性加重。与RS相比,GMP进行了较少的肺活量测定测试,血气分析,并且接受了指南推荐药物治疗的患者较少。两组临床医生转诊肺部康复的情况都很差。 GMP患者的中位住院时间短于RS患者(3天vs. 5天,P = 0.001)。两组患者的12个月再入院率(41.7%vs. 38.5%,P = 0.664)和死亡率(10.7%vs. 6%,P = 0.292)没有差异。结论:我们的研究发现医院对GMP和RS的AECOPD处理存在差异,但并没有转化为患者之间的不同临床结局。我们还发现对国家COPD指南的依从性欠佳,这表明两组临床医生的AECOPD管理都有改进的余地。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号